Harvard professor-turned-Vertex fellow Doug Melton (Stephanie Mitchell/Harvard)

Doug Melton to re­unite with his Sem­ma col­lab­o­ra­tors at Ver­tex to de­vel­op 'cu­ra­tive cell ther­a­pies'

A re­union is hap­pen­ing at Ver­tex Phar­ma­ceu­ti­cals as the bio­phar­ma push­es for­ward its work in type 1 di­a­betes with a lead­ing bi­ol­o­gist set to join next month.

The famed Har­vard stem cell re­searcher Doug Melton is join­ing the cys­tic fi­bro­sis drug­mak­er as the com­pa­ny’s first “Dis­tin­guished Ver­tex Fel­low,” ac­cord­ing to an in­ter­nal memo that Ver­tex shared with End­points News. STAT News first re­port­ed on Melton’s move.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.